• Rapid Haemostatic Action at the Capillary Level: Botrostat targets the smallest and most numerous blood vessels in your pet's body the capillaries restoring their structural resilience and halting the escape of blood into surrounding tissues with clinical speed. This makes it especially valuable in acute post-surgical or trauma scenarios where fast intervention is critical.
• Dual Mechanism: Vessel Wall Repair and Platelet Enhancement: Unlike single-pathway haemostatics, Ethamsylate reinforces haemostasis from two directions simultaneously it both strengthens the vessel wall and boosts platelet stickiness. This dual action offers more comprehensive bleeding control across a wider range of clinical presentations.
• Clinically Validated Across Multiple Species: Botrostat's active ingredient, Ethamsylate, has been documented for use in dogs, cats, horses, and cattle in veterinary literature, with over fifty years of evidence supporting its antihemorrhagic efficacy. Your canine companion or feline friend receives a molecule with a deep and well-studied safety profile.
• Effective in Surgical, Traumatic, and Obstetric Bleeding: Whether your pet is recovering from a procedure, has sustained an injury, or is experiencing gynaecological haemorrhage, Botrostat alleviates excessive bleeding across this diverse range of situations. Its versatility makes it a frontline haemostatic tool in veterinary practice.
• Supports the Body's Natural Clotting Process Without Systemic Anticoagulation Risk: Botrostat does not introduce synthetic clotting factors or disrupt the broader coagulation cascade it works in concert with your pet's own biological systems to accelerate a normal and proportionate haemostatic response. This targeted approach minimises the risk of pathological clot formation.
• Oral Tablet Format for Ease of Administration: Available as a conveniently sized oral tablet, Botrostat can be administered directly or concealed in food as directed by your veterinarian, removing the stress of injection for eligible patients. The tablet format allows for consistent, measurable dosing every time.
• Suitable for Use in Thrombocytopenic Patients: In conditions where platelet counts are reduced such as secondary bleeding disorders associated with tick fever or other systemic disease Ethamsylate maximises the functional adhesiveness of whatever platelets remain in circulation, delivering a meaningful haemostatic effect even in compromised patients.
• Prescribed and Managed by Veterinary Professionals: As a Schedule H prescription pharmaceutical, Botrostat is dispensed only with valid veterinary authorisation, ensuring your pet's bleeding episode is evaluated, diagnosed, and treated within a proper clinical framework.

How to Use:

Botrostat tablets must be administered strictly as prescribed by your veterinarian. The dose, frequency, and duration of treatment will be individually determined based on your pet's species, body weight, the nature and severity of the bleeding condition, and their overall health status.

The tablet may be given orally with or without food; however, administering it with a small meal is preferred to minimise the possibility of gastrointestinal discomfort. Swallow the tablet whole do not crush, break, or dissolve it unless your veterinarian has specifically instructed otherwise for a particular patient.

Do not attempt to self-prescribe or adjust the dose independently. This is a prescription pharmaceutical and must be used only under active veterinary supervision. If your pet shows signs of an adverse reaction including skin rash, vomiting, excessive lethargy, or worsening of the bleeding contact your veterinarian immediately. Do not administer this medication to pregnant or lactating animals unless your veterinarian has expressly assessed the benefit-risk ratio and authorised its use.

Storage Advice:

Botrostat 250 mg tablets should be stored at or below 25°C in a cool, dry place away from direct sunlight and sources of heat. Do not freeze the product. Keep the tablets in their original blister packaging until the point of administration to protect them from humidity and light degradation. Store out of reach of children and other pets at all times. Do not use Botrostat beyond the expiry date printed on the packaging dispose of any expired tablets responsibly and in accordance with your local pharmaceutical waste guidelines.

About the Brand:

Merial was established as one of the world's premier animal health companies, building its global reputation over decades as a trusted developer of veterinary pharmaceuticals, biologicals, and parasiticides across both companion animal and livestock sectors. With operations spanning more than 150 countries, Merial earned international recognition for its rigorous adherence to pharmaceutical manufacturing standards, including GMP-compliant production facilities that consistently delivered medicines of the highest safety and efficacy. The brand's commitment to science-led animal healthcare underpinned by substantial investment in clinical research and veterinary innovation established it as a gold-standard name in practices worldwide. In India, Merial products have been made available through licensed veterinary pharmaceutical channels, ensuring that pet parents and practitioners across the country have access to internationally validated therapeutic solutions. Merial's unwavering dedication to animal wellbeing and evidence-based medicine aligns seamlessly with Animeal's commitment to offering only the most trusted, clinically sound products for your beloved companions. Discover Merial today.

Disclaimer:

Please note that while Botrostat is formulated with the clinically validated pharmaceutical active Ethamsylate and is appropriate for use in dogs and cats under veterinary guidance, it is a prescription-only haemostatic medication and must not be obtained, dispensed, or administered without a valid prescription from a registered veterinary practitioner. This product must be administered by or under the direct supervision of a licensed veterinarian self-administration or self-prescription is unsafe and may result in serious harm to your pet. Botrostat should be used with particular caution in animals with known or suspected liver disease, kidney disease, cardiovascular conditions, or porphyria-related disorders; your veterinarian must be made aware of your pet's full medical history before treatment is initiated. The safety of this medication in pregnant or lactating animals has not been fully established, and use in such cases should only proceed following an explicit benefit-risk assessment by your vet. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.